ScreenCell® joins the European Liquid Biopsy Society (ELBS)

ScreenCell® X ELBS

ScreenCell® becomes an industry member of European Liquid Biopsy Society (ELBS)

ScreenCell® is proud to announce its membership in the European Liquid Biopsy Society (ELBS) as an industry member.

Founded in 2019 and chaired by Prof. Dr. med. Klaus Pantel from the University Medical Center Hamburg-Eppendorf (UKE), ELBS now brings together over 100 European partners from academia, clinical practice, and industry.

This leading scientific society has set itself the ambitious mission of advancing liquid biopsy research and accelerating its deployment in clinical practice.

By joining this network of excellence, ScreenCell® fully participates in strategic discussions and strengthens its collaborations with European stakeholders and members. We are honored to contribute to this essential mission alongside partners who share our vision.

Contact

Quentin DUBIEL

Communications and Webmarketing Officer
qdubiel@screencell.com

Share the article

Our latest news

Liquid biopsy for enhancing patient care through reliable CTC analysis

Want to learn more?

Download our brochure

Follow ScreenCell® on LinkedIn